Pregled bibliografske jedinice broj: 1129869
BBN-driven urinary bladder cancer mouse model
BBN-driven urinary bladder cancer mouse model // Methods in Cell Biology, 163 (2021), 77-92 doi:10.1016/bs.mcb.2020.10.020 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1129869 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BBN-driven urinary bladder cancer mouse model
Autori
Korac-Prlic, Jelena ; Degoricija, Marina ; Vilović, Katarina ; Vujević, Sandra ; Terzić, Janoš
Izvornik
Methods in Cell Biology (0091-679X) 163
(2021);
77-92
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BBN ; Bladder cancer ; Chemical carcinogenesis ; MIBC ; Mouse model ; Smoking
Sažetak
Around 3% of new cancer diagnoses and 2% of all cancer deaths every year are caused by urinary bladder cancer (BC). This indicates a great need for intensive studying of BC by using different approaches including indispensable mice models. The most common preclinical mouse model of bladder carcinogenesis relies on the use of a nitrosamine compound, N-butyl-N-(4- hydroxybutyl)-nitrosamine (BBN) which causes high-grade, invasive tumors in the urinary bladder. BBN-induced bladder cancer in mice recapitulates the histology and manifests genetic alterations similar to human muscle- invasive bladder cancer. Here we present a detailed protocol for the induction of BC in mice which is based on the administration of 0.05%-0.1% BBN in drinking water. Six-to-eight- week-old mice are treated orally with BBN for 12weeks and tumors are expected 8weeks after the termination of BBN regimen. Histopathologic examination of the lesions should be routinely assessed after hematoxylin and eosin staining by an experienced pathologist and it can vary from urothelial dysplasia to invasive bladder cancer with glandular and squamous divergent differentiation, the incidence of which might depend on the mouse strain, gender, BBN concentration and the timeline of the protocol. Utilizing half of the urinary bladder tissue for the isolation and analysis of RNA, DNA and proteins provides a comprehensive insight into the biology of BC and reduces the number of mice per study. Finally, the successful use of the BC model can facilitate fundamental biomedical discoveries leading to novel diagnostic and therapeutic approaches with clinical benefits.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-1904 - Uloga upale u razvoju zloćudnog tumora mokraćnog mjehura (iBC) (Terzić, Janoš, HRZZ ) ( CroRIS)
HRZZ-UIP-2019-04-6680 - Imunomodulacijski učinci mastocita i eozinofila u mikrookolišu tumora mokraćnog mjehura (emBC) (Korać Prlić, Jelena, HRZZ ) ( CroRIS)
Ustanove:
KBC Split,
Medicinski fakultet, Split
Profili:
Janoš Terzić
(autor)
Jelena Korać Prlić
(autor)
Marina Degoricija
(autor)
Katarina Vilović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE